Sale!

LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the LHFPL5 gene, which are associated with autosomal recessive nonsyndromic hearing loss (DFNB67). This condition is characterized by the absence of hearing from birth or early childhood without other associated symptoms. The LHFPL5 gene plays a critical role in the development and function of the inner ear structures responsible for sound transmission.

This genetic test is crucial for families with a history of hearing loss, providing them with an accurate diagnosis and helping to guide potential treatment options or interventions. Early detection through this test can significantly impact the quality of life of affected individuals by facilitating timely access to hearing aids, cochlear implants, or other supportive measures.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures precision, confidentiality, and reliability. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results accurately. DNA Labs UAE employs cutting-edge technology and follows strict international standards to ensure the highest quality of service.

By opting for the LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test, individuals and families gain valuable insights into their genetic makeup, empowering them with the knowledge to make informed decisions about their health and well-being.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test

At DNA Labs UAE, we offer the LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test. This test is designed to diagnose individuals with suspected LHFPL5 gene deafness, autosomal recessive type 67 and provide information about the inheritance pattern of the condition.

Test Details

LHFPL5 gene deafness, autosomal recessive type 67 is a specific type of deafness that is caused by mutations in the LHFPL5 gene. This type of deafness is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for the condition to be present.

Our test uses NGS (Next-Generation Sequencing) technology, which allows us to analyze multiple genes simultaneously. In the case of LHFPL5 gene deafness, autosomal recessive type 67, NGS genetic testing can identify mutations in the LHFPL5 gene that may be causing the deafness.

In addition to diagnosing individuals with suspected LHFPL5 gene deafness, autosomal recessive type 67, our test can also be used for carrier testing. This can help individuals determine if they carry a mutation in the LHFPL5 gene and may be at risk of passing it on to their children.

Test Components and Price

The LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test is priced at 4400.0 AED. The test can be conducted using either blood or extracted DNA, or with just one drop of blood on an FTA Card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test is performed using NGS technology, which ensures accurate and reliable results.

Test Type and Doctor

The LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test falls under the category of Ear Nose Throat Disorders. It is recommended to consult an ENT Doctor for this test.

Test Department and Pre Test Information

The LHFPL5 Gene Deafness Autosomal Recessive Type 67 Genetic Test is conducted in our Genetics department. Before taking the test, it is important to provide the clinical history of the patient who is going for the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with the PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN32.

It is crucial to note that genetic testing for LHFPL5 gene deafness, autosomal recessive type 67 should be done in consultation with a healthcare professional or genetic counselor who can provide guidance and interpretation of the results.

Test Name LHFPL5 Gene Deafness autosomal recessive type 67 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN32
Test Details

LHFPL5 gene deafness, autosomal recessive type 67 is a specific type of deafness that is caused by mutations in the LHFPL5 gene. This type of deafness is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for the condition to be present.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of LHFPL5 gene deafness, autosomal recessive type 67, NGS genetic testing can identify mutations in the LHFPL5 gene that may be causing the deafness.

This type of genetic testing can be useful in diagnosing individuals with suspected LHFPL5 gene deafness, autosomal recessive type 67, as well as in providing information about the inheritance pattern of the condition. It can also be used for carrier testing, which can help individuals determine if they carry a mutation in the LHFPL5 gene and may be at risk of passing it on to their children.

It is important to note that genetic testing for LHFPL5 gene deafness, autosomal recessive type 67 should be done in consultation with a healthcare professional or genetic counselor who can provide guidance and interpretation of the results.